Related Experiment Video
Updated: Sep 10, 2025
09:52
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
10.7K
Future Prospects and Challenges in Mucormycosis Research.
Georgios Chamilos1,2, Ulrike Binder3, Victoriano Garre4
1Laboratory of Clinical Microbiology and Microbial Pathogenesis, School of Medicine, University of Crete, 71110 Heraklion, Greece.
Journal of Fungi (Basel, Switzerland)
|August 27, 2025
Summary
Mucormycosis is a severe fungal infection with few treatments and diagnostic tools. Understanding its immune response is crucial for developing better therapies against this life-threatening condition.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Mucormycosis is a life-threatening fungal infection caused by Mucorales.
- It presents significant challenges due to limited therapeutic options and diagnostic biomarkers.
- The immunopathogenesis of mucormycosis remains incompletely understood.
Discussion:
- The study addresses the critical need for improved understanding of mucormycosis.
- It highlights the challenges in early diagnosis and treatment of this invasive fungal infection.
- Further research into the host-pathogen interactions is essential.
Key Insights:
- Mucormycosis poses a growing threat in human health.
- Current therapeutic strategies for mucormycosis are insufficient.
- Early diagnostic markers and a clearer picture of immune responses are urgently needed.
Outlook:
- Future research should focus on identifying novel therapeutic targets.
- Development of sensitive biomarkers for early mucormycosis detection is a priority.
- Elucidating the immunopathogenesis will pave the way for effective interventions.
Related Concept Videos
01:29Fungal Group Zygomycota
119
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
119
01:28Fungal Phylum Microsporidia
111
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
111
01:29Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
01:23Cystic Fibrosis: Pathogenesis
358
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
358